Compared with the significantly increased risk of MI with high sensitivity CRP values above 1 mg/L among the general population [28], our data suggest that the complete suppression of systemic inflammation in RA may reduce the risk of MI. This evidence concerns the gene CRP and rheumatoid arthritis.